General Сontext of Sales Revenues in Agricultural Entities in the Republic of Moldova: the Case of "Grioniver-Agro" LLC
Economica · 2026-02 · (4) · 97-106
DOI: 10.53486/econ.2025.134.09 ↗Kurz gefasst
Fachartikel in der Zeitschrift Economica, 2026-02. Verfasst von Ina Dombrovschi. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The economic activity of agricultural entities is strongly influenced by the level and structure of their revenues, which are an essential indicator of financial performance. Given the variable nature of the agricultural sector, the analysis of sales revenues constitutes an important tool for assessing the efficiency of the economic activities carried out. In this context, the present study examines the overall income situation within the agricultural entity "Grioniver-Agro" LLC in the Republic of Moldova. The evolutionary nature of sales revenues over the last five years was studied, as well as their structure by type of activity and product. The findings indicate that the main source of income for the enterprise is income from the sale of agricultural production, which in 2024 accounted for 93,61%. At the same time, research has shown that the income obtained covered all expenses and generated a net profit of MDL 2,7 million.
Zitieren
APA
Dombrovschi, I. (2026). General Сontext of Sales Revenues in Agricultural Entities in the Republic of Moldova: the Case of "Grioniver-Agro" LLC. Economica, 97-106. https://doi.org/10.53486/econ.2025.134.09
Vancouver
Dombrovschi I. General Сontext of Sales Revenues in Agricultural Entities in the Republic of Moldova: the Case of "Grioniver-Agro" LLC. Economica. 2026:97-106. doi:10.53486/econ.2025.134.09
BibTeX
@article{Dombrovschi2026,
author = {Dombrovschi, Ina},
title = {General Сontext of Sales Revenues in Agricultural Entities in the Republic of Moldova: the Case of "Grioniver-Agro" LLC},
journal = {Economica},
year = {2026},
number = {4},
pages = {97--106},
doi = {10.53486/econ.2025.134.09}
}
EUVIMED